Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
Albireo Pharma, Inc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders.
Source: https://www.americanbankingnews.com/2023/01/11/albireo-pharma-nasdaqalbo-downgraded-by-cowen.html
Cowen downgraded shares of Albireo Pharma to a “market perform” rating and lowered their price objective for the stock from $68.00 to $48.00 in a research note on Wednesday, January 11th.
Franklin Resources Inc. boosted its holdings in shares of Albireo Pharma by 82.5% in the second quarter.
Source: https://www.americanbankingnews.com/2023/01/11/albireo-pharma-nasdaqalbo-downgraded-by-cowen.html
In other Albireo Pharma news, CEO Ronald Harold Wilfred Cooper sold 1,057 shares of the company’s stock in a transaction dated Monday, January 23rd.
Jefferies Financial Group downgraded shares of Albireo Pharma from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $49.00 to $42.00 in a research note on Wednesday, January 11th.